AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,679,000 | -86.7% | 2,100,000 | -86.9% | 0.08% | -87.6% |
| Q1 2020 | $12,603,000 | -34.0% | 16,000,000 | -28.9% | 0.61% | -40.1% |
| Q4 2019 | $19,088,000 | -15.4% | 22,500,000 | -16.7% | 1.02% | -26.0% |
| Q3 2019 | $22,575,000 | -23.5% | 27,000,000 | -26.1% | 1.38% | -7.1% |
| Q2 2019 | $29,507,000 | -16.5% | 36,525,000 | -8.7% | 1.49% | -29.0% |
| Q1 2019 | $35,342,000 | -3.3% | 40,025,000 | 0.0% | 2.09% | -13.2% |
| Q4 2018 | $36,560,000 | -13.5% | 40,025,000 | 0.0% | 2.41% | -4.8% |
| Q3 2018 | $42,276,000 | +7.5% | 40,025,000 | +5.3% | 2.53% | +7.7% |
| Q2 2018 | $39,317,000 | +50.3% | 38,025,000 | +52.1% | 2.35% | +42.0% |
| Q1 2018 | $26,159,000 | +73.0% | 25,000,000 | +42.9% | 1.66% | +44.0% |
| Q4 2017 | $15,120,000 | -12.4% | 17,500,000 | 0.0% | 1.15% | -14.5% |
| Q3 2017 | $17,269,000 | -6.0% | 17,500,000 | -7.9% | 1.34% | -20.1% |
| Q2 2017 | $18,371,000 | – | 19,000,000 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|